{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:43Z","timestamp":1787020843197,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nailfold videocapillaroscopy (NVC) is a feasible method that allows the observation of the microvascular changes that mark the course of systemic sclerosis (SSc). In previous studies, we demonstrated that the NEMO score, i.e. the cumulative number of microhaemorrhages and microthromboses, is a good indicator of the steady-state level and overtime changes of disease activity (DA) in SSc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To verify whether high NEMO scores, which mirror a very active microvascular derangement in the fingers, may be associated with the subsequent development of ischaemic digital ulcers (IDUs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The NEMO score was assessed at baseline (T0) in 98 patients with SSc, all classified according to the ACR-EULAR criteria. Of them, 90 were females, 48 had the limited and 50 had the diffuse cutaneous variant of SSc. Afterwards, the patients were closely followed up for 2\u00a0years, and the appearance of new IDUs recorded at any time of the follow-up. The T0-NEMO score values of patients who developed IDUs were compared to those of patients who did not. A receiver operating curve (ROC) was constructed, and the area under the curve (AUC) calculated by plotting the sensitivity and 1-specificity of the different NEMO score values in predicting the subsequent development of IDUs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During the follow-up, 38 out of 98 patients developed one or more IDUs. The NEMO score at T0 was significantly higher in those who developed IDUs with respect to those who did not [median 14.5 (95% CI 11.0\u201321.5) and 4.5 (95% CI 4.0\u20136.0), respectively,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u20090.0001]. The ROC curve derived from different T0-NEMO score values had an AUC of 0.79 (95% CI 0.69\u20130.86,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u20090.0001). A NEMO score of \u2265\u200912 had a sensitivity of 83.3% (95% CI 71.5\u201391.7) and a specificity of 63.2% (95% CI 46.0\u201378.2), with positive (P) and negative (N) predictive (PV) values of 58.9% (95% CI 44.7\u201372.2) and 85.6% (71.8\u201394.4), respectively. A NEMO score of \u2265\u200916 had a sensitivity of 95.0% (95% CI 86.1\u201399.0) and a NPV of 93.4% (77.5\u201399.2).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Being a valid tool to measure DA levels in SSc, the NEMO score also appears to be closely related to the subsequent development of IDUs in this disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-020-02342-5","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T08:03:29Z","timestamp":1602576209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis"],"prefix":"10.1186","volume":"22","author":[{"given":"Nicoletta","family":"Del Papa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pignataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Maglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina","family":"Minniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Sambataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Sambataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Caporali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"2342_CR1","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.berh.2008.09.001","volume":"22","author":"M Cutolo","year":"2008","unstructured":"Cutolo M, Pizzorni C, Secchi ME, Sulli A. Capillaroscopy. Best Pract Res Clin Rheumatol. 2008;22:1093\u2013108.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2342_CR2","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/art.23555","volume":"58","author":"F Ingegnoli","year":"2008","unstructured":"Ingegnoli F, Boracchi P, Gualtierotti R, Lubatti C, Meani L, Zahalkova L, et al. Prognostic model based on nailfold capillaroscopy for identifying Raynaud\u2019s phenomenon patients at high risk for the development of a scleroderma spectrum disorder. Arthritis Rheumatol. 2008;58:2174\u201382.","journal-title":"Arthritis Rheumatol"},{"key":"2342_CR3","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/ard.2007.079756","volume":"67","author":"A Sulli","year":"2008","unstructured":"Sulli A, Secchi ME, Pizzorni C, Cutolo M. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis. 2008;67:885\u20137.","journal-title":"Ann Rheum Dis"},{"key":"2342_CR4","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Van den Hoogen","year":"2013","unstructured":"Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative. Arthritis Rheumatol. 2013;65:2737\u201347.","journal-title":"Arthritis Rheumatol"},{"key":"2342_CR5","first-page":"155","volume":"27","author":"M Cutolo","year":"2000","unstructured":"Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol. 2000;27:155\u201360.","journal-title":"J Rheumatol"},{"key":"2342_CR6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s13075-014-0462-8","volume":"16","author":"D Sambataro","year":"2014","unstructured":"Sambataro D, Sambataro G, Zaccara E, Maglione W, Polosa R, Afeltra AM, et al. Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis. Arthritis Res Ther. 2014;16:462\u20139.","journal-title":"Arthritis Res Ther"},{"key":"2342_CR7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13075-017-1354-5","volume":"19","author":"R Andracco","year":"2017","unstructured":"Andracco R, Irace R, Zaccara E, Vettori S, Maglione W, Riccardi A, et al. The cumulative number of micro-haemorrhages and micro-thromboses in nailfold videocapillaroscopy is a good indicator of disease activity in systemic sclerosis: a validation study of the NEMO score. Arthritis Res Ther. 2017;19:133\u201341.","journal-title":"Arthritis Res Ther"},{"key":"2342_CR8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13075-019-2032-6","volume":"21","author":"F Pignataro","year":"2019","unstructured":"Pignataro F, Maglione W, Minniti A, Sambataro D, Sambataro G, Campanaro F, et al. NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: a comparison with the proposed composite indices for this disease status entity. Arthritis Res Ther. 2019;21:258\u201364.","journal-title":"Arthritis Res Ther"},{"key":"2342_CR9","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.60.6.592","volume":"60","author":"G Valentini","year":"2001","unstructured":"Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D\u2019Angelo S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis. 2001;60:592\u20138.","journal-title":"Ann Rheum Dis"},{"key":"2342_CR10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/ard.62.9.901","volume":"62","author":"G Valentini","year":"2003","unstructured":"Valentini G, Bencivelli W, Bombardieri S, D\u2019Angelo S, Della Rossa A, Silman AJ, et al. European multicenter study to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis. 2003;62:901\u20133.","journal-title":"Ann Rheum Dis"},{"key":"2342_CR11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","volume":"76","author":"G Valentini","year":"2017","unstructured":"Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, et al. The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis. 2017;76:270\u20136.","journal-title":"Ann Rheum Dis"},{"key":"2342_CR12","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202\u20135.","journal-title":"J Rheumatol"},{"key":"2342_CR13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mvr.2017.03.001","volume":"112","author":"G Maldonado","year":"2017","unstructured":"Maldonado G, Guerrero R, Paredes C, R\u00edos C. Nailfold capillaroscopy in diabetes mellitus. Microvasc Res. 2017;112:41\u20136.","journal-title":"Microvasc Res"},{"key":"2342_CR14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mvr.2019.03.004","volume":"124","author":"EP Yuksel","year":"2019","unstructured":"Yuksel EP, Yuksel S, Soylu K, Aydin F. Microvascular abnormalities in asymptomatic chronic smokers: a videocapillaroscopic study. Microvasc Res. 2019;124:51\u20133.","journal-title":"Microvasc Res"},{"key":"2342_CR15","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/rheumatology\/keh233","volume":"43","author":"JL Vaz","year":"2004","unstructured":"Vaz JL, Dancour MA, Bottino DA, Bouskela E. Nailfold videocapillaroscopy in primary antiphospholipid syndrome (PAPS). Rheumatology (Oxford). 2004;43:1025\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"2342_CR16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/17434440.2017.1409113","volume":"14","author":"K Thevissen","year":"2017","unstructured":"Thevissen K, Gyselaers W. Capillaroscopy in pregnancy. Expert Rev Med Devices. 2017;14(12):961\u20137.","journal-title":"Expert Rev Med Devices"},{"issue":"3","key":"2342_CR17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006389","volume":"5","author":"R Garner","year":"2015","unstructured":"Garner R, Kumari R, Lanyon P, Doherty M, Zhang W. Prevalence, risk factors and associations of primary Raynaud\u2019s phenomenon: systematic review and meta-analysis of observational studies. BMJ Open. 2015;5(3):e006389.","journal-title":"BMJ Open"},{"issue":"5","key":"2342_CR18","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/art.24394","volume":"61","author":"M Sebastiani","year":"2009","unstructured":"Sebastiani M, Manfredi A, Colaci M, et al. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum. 2009;61(5):688\u201394. https:\/\/doi.org\/10.1002\/art.24394.","journal-title":"Arthritis Rheum"},{"key":"2342_CR19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/rheumatology\/ken279","volume":"47","author":"B Kahaleh","year":"2008","unstructured":"Kahaleh B. The microvascular endothelium in scleroderma. Rheumatology (Oxford). 2008;47:14\u20135.","journal-title":"Rheumatology (Oxford)"},{"key":"2342_CR20","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvendimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360:1989\u20132003.","journal-title":"N Engl J Med"},{"key":"2342_CR21","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/art.20116","volume":"50","author":"N Del Papa","year":"2004","unstructured":"Del Papa N, Colombo G, Fracchiolla N, Mazzeo Moronetti L, Ingegnoli F, Maglione W, et al. Circulatin endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheumatol. 2004;50:1296\u2013304.","journal-title":"Arthritis Rheumatol"},{"key":"2342_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/ard.47.1.53","volume":"47","author":"ML Wong","year":"1988","unstructured":"Wong ML, Highton J, Palmer DG. Sequential nailfold capillary microscopy in scleroderma and related disorders. Ann Rheum Dis. 1988;47:53\u201361.","journal-title":"Ann Rheum Dis"},{"key":"2342_CR23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.berh.2013.03.001","volume":"27","author":"M Cutolo","year":"2013","unstructured":"Cutolo M, Sulli A, Smith V. How to perform and interpret capillaroscopy. Best Pract Res Clin Rheumatol. 2013;27:237\u201348.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2342_CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","volume":"81","author":"C Ferri","year":"2002","unstructured":"Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore). 2002;81:139\u201353.","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl 3","key":"2342_CR25","first-page":"19","volume":"48","author":"V Steen","year":"2009","unstructured":"Steen V, Denton CP, Pope JE, Matucci-Cerinic M. Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology. 2009;48(Suppl 3):19\u201324.","journal-title":"Rheumatology"},{"key":"2342_CR26","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","volume":"66","author":"UA Walker","year":"2007","unstructured":"Walker UA, Tyndall A, Czirj\u00e1k L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis. 2007;66:754\u201363.","journal-title":"Ann Rheum Dis"},{"key":"2342_CR27","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","volume":"76","author":"O Kowal-Bieleka","year":"2017","unstructured":"Kowal-Bieleka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017;76:1327\u201339.","journal-title":"Ann Rheum Dis"},{"key":"2342_CR28","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/acr.22018","volume":"65","author":"T Tingey","year":"2013","unstructured":"Tingey T, Shu J, Smuczek J, Pope J. Meta-analysis of healing and prevention of digital ulcers in systemic sclerosis. Arthritis Care Res. 2013;65:1460\u201371.","journal-title":"Arthritis Care Res"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02342-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-020-02342-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02342-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T22:57:06Z","timestamp":1634079426000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02342-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2342"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02342-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-37432\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-37432\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-37432\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-37432\/v4","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,13]]},"assertion":[{"value":"21 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of the \u2018Azienda Socio Sanitaria Territoriale Lombardia, Centro Specialistico Ortopedico Traumatologico Gaetano Pini,\u2019 Milan, where the study was carried out. Written informed consent was obtained from all of the enrolled patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors give their consent for the publication of the study.Written informed consent was obtained from the patients for the publication of their anonymised data published in this article. No identifiable patient data are contained in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"237"}}